Suchergebnisse - "Tascilar, Koray"

PubPharm (7)

1

Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion

enthalten in: Nature communications | 2020

von Simon, D. | Tascilar, K. | Krönke, G. | +28

2

Clinical course of acute deep vein thrombosis of the legs in Behçet's syndrome

enthalten in: Rheumatology (Oxford, England) | 2020

von Ozguler, Y. | Hatemi, G. | Cetinkaya, F. | +6

CommentIn: Rheumatology (Oxford). 2020 Apr 1;59(4):914-915. - PMID 32003805

3

Effect of disease-modifying anti-rheumatic drugs on bone structure and strength in psoriatic arthritis patients

enthalten in: Arthritis research & therapy | 2019

von Simon, D. | Kleyer, A. | Bayat, S. | +9

4

Colchicine in Behçet syndrome : a longterm survey of patients in a controlled trial

enthalten in: The Journal of rheumatology | 2014

von Hamuryudan, V. | Hatemi, G. | Tascilar, K. | +6

5

Multiple sclerosis during adalimumab treatment in a case with ankylosing spondylitis

enthalten in: Rheumatology international | 2014

von Uygunoğlu, U. | Uluduz, D. | Taşçılar, K. | +1

6

Should immunosuppressives be stopped in granulomatosis with polyangiitis (Wegener's granulomatosis) patients undergoing dialysis?

enthalten in: Clinical and experimental rheumatology | 2012

von Büyüktas, D. | Hatemi, G. | Tascilar, K. | +2

7

Prognosis of Behcet's syndrome among men with mucocutaneous involvement at disease onset : long-term outcome of patients enrolled in a controlled trial

enthalten in: Rheumatology (Oxford, England) | 2010

von Hamuryudan, V. | Hatemi, G. | Tascilar, K. | +6

1
[1]